Prothena announced that the Company has initiated an approximate 63% reduction in its workforce.

The U.K.-based biotech is set to enter mid-stage studies for its depression drug this year, while two other GABAA modulators ...

Oscar Health, Inc. (NYSE:OSCR) is one of the 10 Stocks Boast Whopping Gains Amid Market Downturn. Oscar Health grew its share ...

Bristol Myers Squibb is teaming up with Prothena in a high-stakes lab dance to tackle Alzheimer’s disease with two ...